Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Tenney, Troy [1 ]
Sica, Gabriel [2 ]
Saxe, Debra [3 ]
Owonikoko, Taofeek [3 ]
Ramalingam, Suresh [3 ]
Zhang, Linsheng [2 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1961
引用
收藏
页码：1821 / 1821
页数：1
相关论文
共 50 条
  • [21] Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
    Lalani, Aly-Khan A.
    Gray, Kathryn P.
    Albiges, Laurence
    Callea, Marcella
    Pignon, Jean-Christophe
    Pal, Soumitro
    Gupta, Mamta
    Bhatt, Rupal S.
    McDermott, David F.
    Atkins, Michael B.
    Vande Woude, G. F.
    Harshman, Lauren C.
    Choueiri, Toni K.
    Signoretti, Sabina
    ONCOTARGET, 2017, 8 (61) : 103428 - 103436
  • [22] Evaluation of PD-L1 mRNA and protein expression in non-small cell lung and hepatocellular carcinoma
    Jaeger, Savina
    Lee, Benjamin H.
    Mosher, Rebecca
    Shebnova, Olga
    Wang, Yan
    Yu, Yenyen
    Yang, David
    Murakami, Masato
    Greshock, Joel
    Schlegel, Robert
    Boral, Anthony
    Cao, Zhu Alexander
    CANCER RESEARCH, 2015, 75
  • [23] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Association of PD-L1 protein expression and TMB in non-small cell lung cancer.
    Chen, Yaru
    Zhou, Yanqing
    Xu, Yun
    Zhang, Xiaoni
    Xu, Mingyan
    Melancon, Charles E.
    Chen, Shifu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Interplay of PD-L1 Expression and Clinical Variables in Non-Small Cell Lung Carcinoma Patients
    Sarova, P.
    Mosleh, B.
    Hoda, M. A.
    Gompelmann, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 566 - 567
  • [26] Associations of the immune microenvironment with PD-L1 copy number alterations and PD-L1 expression in resected non-small cell lung cancer
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Kahyo, Tomoaki
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Inui, Naoki
    Funai, Kazuhito
    Shinmura, Kazuya
    Niwa, Hiroshi
    Suda, Takafumi
    Sugimura, Haruhiko
    CANCER RESEARCH, 2017, 77
  • [27] c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers
    Tsuta, K.
    Yoshida, A.
    Tsuda, H.
    LABORATORY INVESTIGATION, 2011, 91 : 426A - 426A
  • [28] Discordance on Repeat PD-L1 Testing in Non-Small Cell Lung Carcinoma
    Naso, J.
    Banyi, N.
    Al-Hashami, Z.
    Wang, G.
    Ionescu, D.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S445 - S445
  • [29] Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
    Zhao, Yanjie
    Shi, Feng
    Zhou, Quan
    Li, Yuchen
    Wu, Jiangping
    Wang, Ruibin
    Song, Qingkun
    MEDICINE, 2020, 99 (45) : E23172
  • [30] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
12345